Twistlock 411 NW Park Ave, Suite 500Portland, OR 97209844-894-7856http://www.twistlock.com/ Key contact Name Title Ben Bernstein CEO PORTLAND, OR, Leader in container and cloud native cyber security, today announced it raised $33 million in Series C funding, led by ICONIQ Capital. Twistlock, the leader in container and cloud native cyber security, today announced it raised $33 […]
Archivio Categoria: series C
14
Ago
Ago
meQuilibrium 260 Franklin Street, Suite 600Boston, MA 02110http://mequilibrium.com/ Key contact Name Title Jan Bruce CEO BOSTON, MA, meQuilibrium, the leading human capital solution grounded in the science of resilience, announced $7 million in Series C funding. meQuilibrium, the leading human capital solution grounded in the science of resilience, announced $7 million in Series C funding […]
Profusa 345 Allerton AvenueSouth San Francisco, CA 94080415-655-9861http://profusa.com/ Key contact Name Title Ben Hwang CEO SOUTH SAN FRANCISCO, CA, Profusa today announced it has raised more than $45 million in a Series C financing. Profusa, a company dedicated to the development of tissue-integrating biosensors for continuous monitoring of body chemistries, today announced it has raised […]
14
Ago
Ago
Orchard Therapeutics 2 Seaport Lane, 8th floorBoston, MA 02210781-608-3666http://www.orchard-tx.com/ Key contact Name Title Mark Rothera President & CEO BOSTON, MA, Orchard Therapeutics has raised a further $150 million to fund its work in gene therapy, building on earlier fundraisings worth more than $140 million. Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives […]
Akili Interactive BOSTON, MA, Akili Interactive has raised $13 million in new funding as an extension of its Series C financing. Akili Interactive ("Akili" or "Company"), a leading prescription digital medicine company developing novel treatments for cognitive dysfunction and brain-related conditions, has raised $13 million in new funding as an extension of its Series C […]
08
Ago
Ago
SQZ Biotech 134 Coolidge AvenueWatertown, MA 02472617-758-8672http://sqzbiotech.com/ Key contact Name Title Armon Sharei CEO WATERTOWN, MA, Cell therapy company developing novel treatments for multiple therapeutic areas, has completed an oversubscribed $72M Series C financing. SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, announced the completion of an oversubscribed $72 […]
07
Ago
Ago
StreetLight Data 330 Townsend Street, Suite 117San Francisco, CA 94107415-935-0869www.streetlightdata.com Key contact Name Title Laura Schewel CEO SAN FRANCISCO, CA, StreetLight Data, the mobility analytics company that brings real-world travel patterns to light, today announced that it has closed $10 Million in Series C funding. StreetLight Data's proprietary solution, StreetLight InSight, is an online SaaS […]
01
Ago
Ago
Evidation Health 15 N. Ellsworth Ave, Suite 208San Mateo, CA 94401415-800-2052http://www.evidation.com/ Key contact Name Title Deborah Kilpatrick CEO SAN MATEO, CA, Health and measurement company has raised $30 million in Series C funding. Evidation Health, a health and measurement company that helps life sciences and health care companies understand how everyday behaviors and health interact, […]
31
Lug
Lug
Verana Health 535 Mission Street, #1929San Francisco, CA 94105650-223-5560https://www.veranahealth.com/ Key contact Name Title miki@veranahealth.com President & CEO SAN FRANCISCO, CA, Verana Health, the developer of a cutting-edge platform for life science innovation that utilizes regulatory-grade specialty data sets, today announced a $30 million Series C financing. The round was led by GV (formerly Google Ventures) […]
31
Lug
Lug
Gusto San Francisco, CA 46240844-572-1923https://gusto.com/ Key contact Name Title Josh Reeves CEO & Co-Founder SAN FRANCISCO, CA, Gusto, the leading payroll, benefits and HR technology platform for small businesses, today announced it raised $140 million in a Series C funding round. Leading late-stage investors including portfolios managed by T. Rowe Price Associates, Inc., MSD Capital […]